SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-24-001207
Filing Date
2024-08-06
Accepted
2024-08-06 17:21:05
Documents
50
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e5842_10-q.htm   iXBRL 10-Q 723739
2 EXHIBIT 31.1 e5842_ex31-1.htm EX-31.1 8898
3 EXHIBIT 31.2 e5842_ex31-2.htm EX-31.2 8939
4 EXHIBIT 32.1 e5842_ex32-1.htm EX-32.1 7252
10 GRAPHIC image_001.jpg GRAPHIC 27701
11 GRAPHIC image_002.jpg GRAPHIC 28447
  Complete submission text file 0001731122-24-001207.txt   3632467

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE avxl-20240630.xsd EX-101.SCH 28020
6 XBRL CALCULATION FILE avxl-20240630_cal.xml EX-101.CAL 29473
7 XBRL DEFINITION FILE avxl-20240630_def.xml EX-101.DEF 92932
8 XBRL LABEL FILE avxl-20240630_lab.xml EX-101.LAB 256430
9 XBRL PRESENTATION FILE avxl-20240630_pre.xml EX-101.PRE 203551
52 EXTRACTED XBRL INSTANCE DOCUMENT e5842_10-q_htm.xml XML 453870
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 980608404 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 241180566
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)